NICE Quality Standard for Anaphylaxis (QS119)
The NICE quality standard for anaphylaxis (QS119) provides essential guidance to improve the care and management of individuals at risk of or experiencing anaphylaxis. It emphasises the importance of rapid recognition and treatment of anaphylaxis, the use of adrenaline as the first-line treatment, and ensuring that patients receive appropriate follow-up care, including an assessment by an allergy specialist. The standard also highlights the need for patient education and the provision of adrenaline auto-injectors.
Initial Education in Adrenaline Auto-Injector Use
Proper education on the use of adrenaline auto-injectors is vital for patients who are at risk of anaphylaxis. NICE’s quality statement emphasises that healthcare professionals must provide comprehensive initial training on how and when to use an adrenaline auto-injector. This training should include a practical demonstration, opportunities for the patient or carer to practice with a trainer device, and clear instructions on recognising the signs of anaphylaxis. Ensuring patients are confident in using their auto-injector is crucial for effective emergency management.
Referral to Specialist Allergy Services After Emergency Anaphylaxis Treatment
After a patient receives emergency treatment for anaphylaxis, it is crucial that they are referred to specialist allergy services for further assessment and management. According to NICE’s quality statement, this referral ensures that patients receive a comprehensive evaluation to identify the cause of the anaphylactic reaction and are provided with long-term management strategies, including personalised action plans and prescription of adrenaline auto-injectors. Prompt referral is essential to reduce the risk of future anaphylactic episodes.
Specialist Assessment for Venom Immunotherapy
For patients who have experienced anaphylaxis due to insect stings, referral for a specialist assessment for venom immunotherapy is essential. NICE’s quality statement highlights that this treatment can significantly reduce the risk of future severe allergic reactions. The assessment should be carried out by a specialist who can determine the appropriateness of venom immunotherapy, which can offer long-term protection for individuals with venom allergies, ultimately improving their quality of life and safety.
Ongoing Training in Adrenaline Auto-Injector Use
For individuals at risk of anaphylaxis, ongoing training in the use of adrenaline auto-injectors is vital to ensure they remain confident and prepared in an emergency. NICE’s quality statement stresses the importance of regular, refresher training for patients, carers, and relevant school or workplace staff. This training should reinforce correct usage techniques and include updates on any new information or changes in device design. Consistent education is key to reducing the risk of improper use during an anaphylactic episode.
